What We're Reading: Generic EpiPen Cost; Amazon's Medical Software; European Report on Curbing Spending
A generic competitor to the EpiPen will not cost any less than the version that is already on the market; a new service from Amazon will use machine learning to pull key information from patient records; a new report from the European Commission has noted that generic and biosimilar products will be key to curbing wasteful spending in healthcare.
No Savings on Generic EpiPen
A generic competitor to the EpiPen will not cost any less than the version that is already on the market.
Amazon’s New Software Will Mine Patient Records for Data
A new service from Amazon will use machine learning to pull key information from patient records. Amazon Comprehend Medical can pick out and organize information about diagnoses, treatments, medication dosages, and symptoms in order to help providers make treatment decisions,
European Report Highlights Importance of Generics, Biosimilars
A new report from the European Commission has noted that generic and biosimilar products will be key to curbing wasteful spending in healthcare. The Center for Biosimilars®, a sister site of The American Journal of Managed Care®,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025